Table 2.
Demographic characterictics, hemoglobin levels, clinical diagnoses, SIR values, and biopsy results of group 2.
| Case | Sex | Age | Weight | Hb level (mg/dl) | History of hematological malignancy | SIR | **BM biopsy results |
| 1 | Female | 23 | 54 | 13 | ***( - ) | 0.58 | No BM biopsy Stable at follow-up |
| 2 | Female | 41 | 69 | 12 | ***( - ) | 0.8 | No BM biopsy Stable at follow-up |
| 3 | Female | 27 | 70 | 11 | ***( - ) | 0.67 | No BM biopsy Stable at follow-up |
| 4 | Male | 46 | 85 | 10 | ***( - ) | 0.5 | Hypercellular BM |
| 5 | Female | 37 | 65 | 13 | ***( - ) | 0.81 | Normocellular BM |
| 6 | Male | 61 | 70 | 10 | ***( - ) | 0.73 | Hypercellular BM |
| 7 | Female | 25 | 90 | 14 | ***( - ) | 0.59 | No BM biopsy Stable at follow-up |
| 8 | Male | 61 | 75 | 10 | ***( - ) | 0.65 | No BM biopsy Stable at follow-up |
| 9 | Male | 35 | 60 | 9 | ***( - ) | 1.22 | Hypercellular BM |
| 10 | Female | 39 | 88 | 7 | *(+) | 0.63 | Hypercellular BM |
| 11 | Male | 34 | 70 | 7 | *(+) | 1.3 | Hypercellular BM |
| 12 | Male | 46 | 74 | 9 | *(+) | 1.16 | Hypercellular BM |
| 13 | Female | 54 | 78 | 13 | ***( - ) | 0.69 | No BM biopsy Stable at follow-up |
| 14 | Female | 33 | 72 | 13 | ***( - ) | 0.27 | No BM biopsy Stable at follow-up |
| 15 | Male | 41 | 89 | 14 | ***( - ) | 0.21 | No BM biopsy Stable at follow-up |
| 16 | Female | 51 | 60 | 11 | ***( - ) | 0.35 | No BM biopsy Stable at follow-up |
Hb: Hemoglobin, SIR: Signal intensity ratio, BM: Bone marrow *( + ): Patients who had history of hematological malignancy. **: BM results at at the time of MRI imaging. ***( - ): Patient who had no history of hematological malignancy.